Nucl Med Mol Imaging.  2011 Sep;45(3):217-219.

Assessment of Therapeutic Effect of Sunitinib by 11C-Acetate PET Compared with FDG PET Imaging in a Patient with Metastatic Renal Cell Carcinoma

Affiliations
  • 1Department of Urology, University of Fukui, 23-3 Matsuoka-Shimoaizuki, Eiheiji, Fukui 910-1193, Japan. urono@u-fukui.ac.jp
  • 2Biomedical Imaging Research Center, University of Fukui, Eiheiji, Fukui, Japan.

Abstract

Although sunitinib shows a high response rate in patients with untreated metastatic renal cell carcinoma (mRCC), quite a few patients show no therapeutic effect. Therefore, it is crucial to distinguish the patients who respond to sunitinib from those who do not as early as possible after the administration of the therapy. We herein report a case of mRCC in which 11C-acetate (AC) positron emission tomography (PET) showed an early therapeutic effect of sunitinib treatment 4 weeks after its administration.

Keyword

11C-acetate; Positron emission tomography; Therapeutic effect; Renal cell carcinoma; Sunitinib

MeSH Terms

Carcinoma, Renal Cell
Humans
Indoles
Positron-Emission Tomography
Pyrroles
Indoles
Pyrroles
Full Text Links
  • NMMI
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr